ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AIRE reAlpha Tech Corporation

1.11
-0.28 (-20.14%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5,745,452
Bid Price 1.05
Ask Price 1.11
News -
Day High 1.24

Low
0.5311

52 Week Range

High
523.10

Day Low 1.04
Company Name Stock Ticker Symbol Market Type
reAlpha Tech Corporation AIRE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.28 -20.14% 1.11 19:58:13
Open Price Low Price High Price Close Price Prev Close
1.14 1.04 1.24 1.09 1.39
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
24,059 5,745,452 $ 1.12 $ 6,455,347 - 0.5311 - 523.10
Last Trade Time Type Quantity Stock Price Currency
19:58:13 formt 471 $ 1.11 USD

reAlpha Tech Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
48.53M 44.12M - 122k -1.25M -0.03 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

reAlpha Tech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AIRE Message Board. Create One! See More Posts on AIRE Message Board See More Message Board Posts

Historical AIRE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.69341.660.53111.2916,949,3800.416660.08%
1 Month1.221.660.53111.284,629,423-0.11-9.02%
3 Months1.202.220.53111.432,637,852-0.09-7.50%
6 Months72.0090.210.53113.721,835,945-70.89-98.46%
1 Year23.01523.100.53113.771,793,337-21.90-95.18%
3 Years23.01523.100.53113.771,793,337-21.90-95.18%
5 Years23.01523.100.53113.771,793,337-21.90-95.18%

reAlpha Tech Description

Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Your Recent History

Delayed Upgrade Clock